Trials / Withdrawn
WithdrawnNCT02289274
Study to Compare Pharmacokinetic Characteristics of Eperisone and Aceclofenac With NVP-1203
Partial Replicated Crossover Clinical Study to Compare Pharmacokinetic Characteristics of Eperisone and Aceclofenac With NVP-1203 Treatment to Those of Co-administration of Eperisone Hydrochloride Slow Release and Aceclofenac in Volunteers
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- NVP Healthcare · Industry
- Sex
- Male
- Age
- 19 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the pharmacokinetics of NVP-1203 and coadministration of aceclofenac and eperisone HCl SR.
Detailed description
aceclofenac and eperisone(low back pain)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NVP-1203 | NVP-1203(eperisone SR + aceclofenac) |
| DRUG | Eperisone SR tab. + and Airtal tab. | Eperisone SR and aceclofenac |
Timeline
- Start date
- 2019-11-01
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2014-11-13
- Last updated
- 2019-09-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02289274. Inclusion in this directory is not an endorsement.